Form 4: Relay Therapeutics CFO Sells Shares
Insider Transaction (Form 4)
Thomas Catinazzo, Chief Financial Officer of Relay Therapeutics, Inc., sold 1,459 shares of common stock on July 28, 2026 for $18.61 per share.
Summary
- Open-market sale: disposed of 1,459 Common Stock at $18.61 ($27,152) on July 28, 2026; holds 158,285 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $27,152 of stock on the open market.
Insider Transactions
Thomas Catinazzo — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-28 | Open-market sale | Common Stock | 1,459 | $19 | $27.2K | 158,285 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-28 | Open-market sale (1,459 shares) |
Keywords
insider transaction, Form 4, RLAY, Relay Therapeutics, Inc., bearish, Thomas Catinazzo
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.